pulmonx LUNG 深 滬
等待開盤 09-02 09:30:00 美东时间
1.71
-0.050
-2.84%
華盛通- 最 高1.78
- 今 開1.76
- 成交量 39.84万股
- 最 低 1.70
- 昨 收 1.76
- 總市值 6967.67万
- 52周最高 9.37
- 市盈率 靜 --
- 換手率 0.98%
- 52周最低 1.47
- 委 比 75.85%
- 總股本 4074.66万
- 歷史最高 69.478
- 量 比 0.50
- 振 幅 4.55%
- 歷史最低 1.47
- 每 手 1
- 風險率 2.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jaeger And Pulmonx Announce Strategic Partnership To Integrate Data Qualification Capabilities Into SentrySuite
Jaeger™ Medical, a global leader in respiratory diagnostic products, is pleased to announce a strategic partnership with Pulmonx Corporation, Redwood City, California, USA, to integrate advanced data
08-27 21:13
Pulmonx to Participate in September Investor Conferences
Pulmonx Corporation announces that its management will participate in two investor conferences: the Wells Fargo Healthcare Conference on September 4, 2025, in Boston, featuring a Fireside Chat and 1x1 meetings, and the Lake Street Best Ideas Growth (BIG9) Conference on September 11, 2025, in New York, with 1x1 meetings. A live and archived webcast of the Fireside Chat will be available on the Pulmonx Investors website. Pulmonx, a global leader in...
08-26 20:05
一周医药速览（08.18-08.22）
百奥泰与STADA就托珠单抗注射液签署商业化协议，首付及里程碑款最高至1.36亿欧元 百奥泰发布关于与STADA就BAT1806(托珠单抗)注射液签署授权许可与...
08-22 17:19
中生制药午前涨逾6% 宗艾替尼获CDE突破性治疗资格认定
中生制药（01177）盘中涨超6%，截至发稿，股价上涨5.57%，现报8.15港元，成交额10.84亿港元。 中生制药认为，选择性HER2酪氨酸激酶抑制...
08-22 11:54
百利天恒：与BMS合作的iza-bren用于治疗非小细胞肺癌获FDA突破性疗法认定
近日，百利天恒发布自愿披露关于iza-bren（EGFR×HER3双抗ADC）用于治疗晚期EGFR突变的非小细胞肺癌获得美国FDA突破性疗法认定的公告。 当中披...
08-19 10:14
美股大行评级 | 罕见！Meta、微软连续获多家大行上调目标价；花旗上调Robinhood目标价升至120美元
今日重点评级关注：丰业银行：维持Arcellx"跑赢大市"评级，目标价从93美元升至133美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从89美元升至100美元
08-01 10:17
Analyst Expectations For Pulmonx's Future
In the latest quarter, 4 analysts provided ratings for Pulmonx (NASDAQ:LUNG), s...
08-01 03:00
Piper Sandler Downgrades Pulmonx to Neutral, Lowers Price Target to $2.5
Piper Sandler analyst Jason Bednar downgrades Pulmonx (NASDAQ:LUNG) from Overweight to Neutral and lowers the price target from $9 to $2.5.
07-31 20:10
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Holdings (NASDAQ:OSRH) stock rose 21.4% to $1.05 during Wednesday'...
07-31 05:06
Pulmonx shares are trading lower after the company reported Q2 financial results and cut its FY25 sales guidance below estimates.
Pulmonx shares are trading lower after the company reported Q2 financial result...
07-31 05:04
